Charles B. O'Keeffe, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 20,000 shares at $0.60 ($12K) on 2016-04-26, disclosed to the SEC on 2016-04-27.
Open-market purchase of $12k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CPRX | BUY | 2019-10-11 | $47K | — | Filing → |
| CPRX | BUY | 2018-12-14 | $50K | — | Filing → |
| CPRX | BUY | 2018-06-08 | $3K | — | Filing → |